Covalon Technologies is forecast to grow earnings and revenue by 28.9% and 8.9% per annum respectively. EPS is expected to grow by 28.9% per annum. Return on equity is forecast to be 13% in 3 years.
Key information
28.9%
Earnings growth rate
28.86%
EPS growth rate
Biotechs earnings growth
23.4%
Revenue growth rate
8.9%
Future return on equity
13.00%
Analyst coverage
Low
Last updated
25 Feb 2026
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
OTCPK:CVAL.F - Analysts future estimates and past financials data (CAD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
9/30/2028
44
5
N/A
5
1
9/30/2027
41
4
N/A
4
1
9/30/2026
36
2
N/A
8
1
12/31/2025
32
1
7
8
N/A
9/30/2025
33
2
1
2
N/A
6/30/2025
33
2
4
5
N/A
3/31/2025
34
4
5
5
N/A
12/31/2024
35
5
3
4
N/A
9/30/2024
31
3
3
3
N/A
6/30/2024
29
-1
1
1
N/A
3/31/2024
26
-3
-3
-2
N/A
12/31/2023
25
-5
-4
-3
N/A
9/30/2023
27
-4
-5
-3
N/A
6/30/2023
25
-6
-6
-5
N/A
3/31/2023
23
-7
-9
-8
N/A
12/31/2022
19
-9
-10
-8
N/A
9/30/2022
18
-9
-9
-8
N/A
6/30/2022
19
-4
-8
-8
N/A
3/31/2022
21
-2
-4
-3
N/A
12/31/2021
22
0
0
0
N/A
9/30/2021
20
0
0
0
N/A
6/30/2021
7
-4
1
1
N/A
3/31/2021
7
-4
1
1
N/A
12/31/2020
8
-8
0
0
N/A
9/30/2020
14
-8
-4
-4
N/A
6/30/2020
26
-8
-3
-3
N/A
3/31/2020
27
-12
-4
-4
N/A
12/31/2019
35
-8
-5
-4
N/A
9/30/2019
34
-9
N/A
-3
N/A
6/30/2019
34
-6
N/A
-2
N/A
3/31/2019
35
-1
N/A
-2
N/A
12/31/2018
28
-1
N/A
-4
N/A
9/30/2018
27
2
N/A
-1
N/A
6/30/2018
30
3
N/A
-1
N/A
3/31/2018
28
1
N/A
-1
N/A
12/31/2017
28
2
N/A
0
N/A
9/30/2017
27
2
N/A
0
N/A
6/30/2017
18
-1
N/A
-2
N/A
3/31/2017
15
-1
N/A
-1
N/A
12/31/2016
10
-3
N/A
-1
N/A
9/30/2016
7
-3
N/A
-1
N/A
6/30/2016
8
-2
N/A
-3
N/A
3/31/2016
7
-2
N/A
-3
N/A
12/31/2015
9
0
N/A
-3
N/A
9/30/2015
8
-1
N/A
-2
N/A
6/30/2015
7
-1
N/A
-1
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVAL.F's forecast earnings growth (28.9% per year) is above the savings rate (3.5%).
Earnings vs Market: CVAL.F's earnings (28.9% per year) are forecast to grow faster than the US market (16.4% per year).
High Growth Earnings: CVAL.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CVAL.F's revenue (8.9% per year) is forecast to grow slower than the US market (11.4% per year).
High Growth Revenue: CVAL.F's revenue (8.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CVAL.F's Return on Equity is forecast to be low in 3 years time (13%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/07 06:28
End of Day Share Price
2026/05/07 00:00
Earnings
2025/12/31
Annual Earnings
2025/09/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Covalon Technologies Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.